Skip to content

Alpha pharma

Active
Private limited companyfounded 2014active for 12 yearsOekensestraat 140B, 8800 Roeselare, BelgiumKBO/BCE: BE 0544.737.350

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
23-06
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 38 days before the deadline
2025
18-07
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 13 days before the deadline
2024
31-12
Financial Equity above €500,000equity €569,000 ▲25.2%
With a profit in every financial year since 2018, equity grows to €569,000.
02-10
Gazette deed Company renamed from Apotheek Princen to Alpha pharma
Resignations: PRINCEN Filip, DEQUAE Anna and PRINCEN Johanna · Appointment: JM (director) · Permanent representative: PRINCEN Johanna23 points ▸
  • General meeting, 31-08-2024
  • Name change, Alpha pharma
  • Kind of shares, “onderverdeling, artikel 5:102 WVV” (deed in Dutch)
  • Declaration, “ontvangst verslag, aandeelhouders verklaren en erkennen een afschrift van het verslag te hebben ontvangen en er kennis van te hebben genomen” (deed in Dutch)
  • PRINCEN Johanna holds 372 shares
  • JM holds 1,488 shares
  • Legal-form conversion, “besloten vennootschap” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening 'Onbeschikbare inbreng buiten kapitaal Andere'” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening 'Statutair onbeschikbare reserves'” (deed in Dutch)
  • Capital conversion, “beschikbare eigen vermogensrekening 'Beschikbare inbreng buiten kapitaal Andere'” (deed in Dutch)
  • Capital conversion, “beschikbare eigen vermogensrekening 'Beschikbare reserves'” (deed in Dutch)
  • Declaration, “statutair onbeschikbaar eigen vermogen, de vennootschap heeft geen statutair onbeschikbaar eigen vermogen” (deed in Dutch)
  • The act holds 11 more points.

Open the act in the Belgian Official Gazette

08-08
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 8 days late
2023
22-06
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 39 days before the deadline
2022
08-11
Gazette deed Resignation: Princen Bert (director)
Permanent representative: Hutsebaut Geert4 points ▸
  • General meeting, 19-08-2022
  • Director resignation, Princen Bert (director)
  • Other provision, “kwijting bestuurder, uitgesteld tot eerstvolgende gewone algemene vergadering” (deed in Dutch)
  • Permanent representative, Hutsebaut Geert

Open the act in the Belgian Official Gazette

31-08
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 31 days late
2021
31-12
Financial Highest result from 2018 to 2025net €170,760 ▲108%
The operating result of €234,936 and the net result of €170,760 are both a record.
31-12
Financial Equity above €500,000equity €572,473 ▲42.5%
With a profit in every financial year since 2018, equity grows to €572,473.
26-08
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 26 days late
2020
12-10
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 73 days late
Show earlier events
2019
29-07
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 2 days before the deadline
2018
23-08
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 23 days late
2017
31-07
NBB filing Annual accounts 2016 filedPDF
abbreviated format · on the deadline day
2014
04-02
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 17 January 2014, Alpha pharma was incorporated.1 The name was changed to Alpha pharma in 2024.2 Total assets went from €1.3m in 2018 to €1.5m in 2025 and headcount from 0.5 full-time equivalents in 2019 to 2.2 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 02-10-2024
  3. 3National Bank, annual accounts 2018, 2019 and 2025

Next steps